GSK3B and neoplasm: Using RNA sequencing, these cells were shown to have upregulated the protein RSG14, which competitively inhibited the GSK-3β-mediated phosphorylation of β-catenin, subsequently leading to nuclear translocation and downstream transcriptional changes to facilitate tumour epithelial–mesenchymal transition (EMT) [60].